Patents by Inventor Sameeh M. Salama

Sameeh M. Salama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LACTIVICIN COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS
    Publication number: 20230374005
    Abstract: Lactivicin compounds of formula (I) and pharmaceutically acceptable salts of the compounds of formula (I) are provided, wherein the compounds comprise antibiotics suitable for use either alone or in combination with ?-lactamase inhibitors and/or additional antibiotics (including ?-lactam and non-?-lactam antibiotics) in the treatment or prevention of bacterial infections.
    Type: Application
    Filed: July 25, 2023
    Publication date: November 23, 2023
    Applicant: FEDORA PHARMACEUTICALS INC.
    Inventors: Renata JANKOWSKA, Sameeh M. SALAMA, Samarendra N. MAITI
  • Lactivicin compounds, their preparation and use as antibacterial agents
    Patent number: 11780832
    Abstract: Lactivicin compounds of formula (I) and pharmaceutically acceptable salts of the compounds of formula (I) are provided, wherein the compounds comprise antibiotics suitable for use either alone or in combination with ?-lactamase inhibitors and/or other antibiotics (including ?-lactam and non-?-lactam antibiotics) in the treatment or prevention of bacterial infections.
    Type: Grant
    Filed: March 29, 2022
    Date of Patent: October 10, 2023
    Assignee: FEDORA PHARMACEUTICALS INC.
    Inventors: Renata Jankowska, Sameeh M. Salama, Samarendra N. Maiti
  • PHARMACEUTICAL COMPOSITIONS COMPRISING LTV-17 AND BETA-LACTAMASE INHIBITORS AND THEIR USE AS ANTIBACTERIAL AGENTS
    Publication number: 20230149368
    Abstract: Pharmaceutical combinations of LTV-17 (I), a lactivicin derivative, and ?-lactamase inhibitors are provided, wherein the combinations comprise antibacterial agents suitable for use in the treatment or prevention of bacterial infections.
    Type: Application
    Filed: November 10, 2022
    Publication date: May 18, 2023
    Applicant: FEDORA PHARMACEUTICALS INC.
    Inventors: Sameeh M. SALAMA, Samarendra N. MAITI, Renata JANKOWSKA
  • LACTIVICIN COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS
    Publication number: 20220324858
    Abstract: Lactivicin compounds of formula (I) and pharmaceutically acceptable salts of the compounds of formula (I) are provided, wherein the compounds comprise antibiotics suitable for use either alone or in combination with ?-lactamase inhibitors and/or other antibiotics (including ?-lactam and non-?-lactam antibiotics) in the treatment or prevention of bacterial infections.
    Type: Application
    Filed: March 29, 2022
    Publication date: October 13, 2022
    Applicant: FEDORA PHARMACEUTICALS INC.
    Inventors: Renata JANKOWSKA, Sameeh M. SALAMA, Samarendra N. MAITI
  • 3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents
    Patent number: 6916803
    Abstract: The present invention relates to novel Syn isomers of racemates and optical isomers of 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids of the following formula: and their use in treating infections caused by gram-negative pathogenic bacteria.
    Type: Grant
    Filed: September 14, 2001
    Date of Patent: July 12, 2005
    Assignee: Pantherix, Ltd.
    Inventors: Ronald George Micetich, Samarendra Maiti, Charles Fiakpui, George Thomas, Andhe V. Narender Reddy, Sameeh M. Salama, Rajeshwar Singh
  • 3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents
    Publication number: 20040019203
    Abstract: The present invention relates to novel Syn isomers of racemates and optical isomers of 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids of formula (I) and its use in treating the infections caused by gram-negative pathogenic bacteria.
    Type: Application
    Filed: February 27, 2003
    Publication date: January 29, 2004
    Inventors: Ronald George Micetich, Samarendra Maiti, Charles Fiakpui, George Thomas, Andhe V. Narender Reddy, Sameeh M. Salama, Rajeshwar Singh
  • Microsphaeropsin B as novel antibacterial agent, process for producing the same and pharmaceutical composition containing thereof
    Publication number: 20030166707
    Abstract: One of the aspects of the present invention is directed to tetramic acid derivatives useful in treating or preventing bacterial diseases, especially diseases caused by gram-positive pathogens resistant to antibiotics of the prior art. Within the scope of the present invention are pharmaceutical compositions containing at least one of the tetramic acid derivatives of the invention as the active ingredient, methods of treating and/or preventing a bacterial disease by administering at least one of the tetramic acid derivatives of the invention, and the use of the tetramic acid derivatives of the invention in the treatment and/or prevention of a bacterial disease. Preferably, the tetramic acid derivative of the invention is a compound of formula IV shown below.
    Type: Application
    Filed: October 17, 2002
    Publication date: September 4, 2003
    Inventors: Chao-Mei Yu, Stephen W. Ayer, Ronald G. Micetich, Sameeh M. Salama, Rakhshandeh Fathi-Afshar, Jonathan M. Curtis, Jeffrey Lawson Cameron Wright